Transfer of Cardiac Mitochondria Improves the Therapeutic Efficacy of Mesenchymal Stem Cells in a Preclinical Model of Ischemic Heart Disease

Background: The use of mesenchymal stem cells (MSCs) appears to be a promising therapeutic approach for cardiac repair after myocardial infarction. However, clinical trials have revealed the need to improve their therapeutic efficacy. Recent evidence demonstrated that mitochondria undergo spontaneou...

Descripción completa

Detalles Bibliográficos
Autores principales: Vignais, Marie-Luce, Levoux, Jennyfer, Sicard, Pierre, Khattar, Khattar, Lozza, Catherine, Gervais, Marianne, Mezhoud, Safia, Nakhle, Jean, Relaix, Frederic, Agbulut, Onnik, Fauconnier, Jeremy, Rodriguez, Anne-Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953768/
https://www.ncbi.nlm.nih.gov/pubmed/36831249
http://dx.doi.org/10.3390/cells12040582

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953768/
https://www.ncbi.nlm.nih.gov/pubmed/36831249
http://dx.doi.org/10.3390/cells12040582

Ejemplares similares